LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - UroGen Pharma (NASDAQ: URGN)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ URGN UroGen Pharma
Schoenberg Mark / officer: Chief Medical Officer
11/19/2025
Sell
$25.00
10,000
$250K
139,025
NASDAQ URGN UroGen Pharma
Degnan Chris / officer: Chief Financial Officer
10/08/2025
Sell
$16.85
2,203
$37K
2,280